Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
4,807 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Formulation Matters: Nutrient Availability and Label Accuracy of Supplements for Age-Related Macular Degeneration.
de Koning-Backus ASPM, Kiefte-de Jong JC, Berendschot TJM, Smoor MA, Klaver CCW. · Invest Ophthalmol Vis Sci · 2026 · cited 0 timesrandomized controlled trial
- Renal Impairment and Age-Related Macular Degeneration: A Comprehensive Systematic Review and Meta-Analysis.
Alamoudi A, Alnabihi A, Almufarriji N, Sawad MHB, HELMi KW, Batais W, Althagafi LA, Aljiayyd AAS, Batawi H, Abdulkarem M. · Am J Ophthalmol · 2026 · cited 0 timesmeta-analysis, systematic review
- The Effect of Resveratrol, Quercetin, and Curcumin on Drusen Volume in Age-Related Macular Degeneration: A Randomized Clinical Trial.
Pfahler NM, Knepper PA. · Transl Vis Sci Technol · 2026 · cited 0 timesOpen accessclinical trial, phase ii, randomized controlled trial
- ASSOCIATIONS BETWEEN SLEEP DISORDERS AND AGE-RELATED MACULAR DEGENERATION: A Systematic Review and Meta-Analysis.
Nascimento LM, Louzada R, Amaral DC, Jacometti R, Mendonça VPV, Chamis B, Gonzalez JVP, Lessa CT, Monteiro MLR, Ferrara D. · Retina · 2026 · cited 0 timesmeta-analysis, systematic review
- Early Versus Delayed Pegcetacoplan Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration in OAKS, DERBY, and GALE.
Dhoot DS, Singerman LJ, Ferrone PJ, Wykoff CC, Goldberg RA, Guymer RH, Kim EL, Maccumber MW, Maia A, Yu S, Yemanyi F, Coughlin BA, Baumal CR, Holz FG, OAKS, DERBY, AND GALE INVESTIGATORS. · Am J Ophthalmol · 2026 · cited 0 timesclinical trial, phase iii, multicenter study
- Performance of Deep Learning in Classifying Age-Related Macular Degeneration From Images: Systematic Review and Meta-Analysis.
Zhu Y, Niu Y, Sun S, Liu W, Dou Y, Guo Y. · J Med Internet Res · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Biomarkers for detecting and predicting macular neovascularization in age-related macular degeneration using optical coherence tomography angiography: a systematic review.
Pourbagherkhah P, Baghban Jaldian H. · Photodiagnosis Photodyn Ther · 2026 · cited 0 timessystematic review
- Risk factors for age-related macular degeneration: an umbrella analysis of systematic review and meta-analysis.
Zang H, Han L, Shi D. · Front Med (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Radiotherapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
Lei Y, Yang J, Li Y, Xiao B, Lai D, Qiu Q. · Curr Eye Res · 2026 · cited 0 timesmeta-analysis, systematic review
- Comparative efficacy and safety of Ranibizumab and Aflibercept for neovascular age-related macular degeneration: a systematic review and meta-analysis.
Zhao X, Yang Y. · BMC Ophthalmol · 2026 · cited 0 timesOpen accessmeta-analysis, comparative study
- Genetic determinants of age-related macular degeneration in Middle Eastern populations: a systematic review.
Sannan NS. · Front Genet · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Efficacy and Safety of Gene Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
Chen KY, Chan HC, Chan CM. · Am J Ophthalmol · 2026 · cited 0 timesmeta-analysis, systematic review
- Effect of a mobile application-based whole-course nutrition management intervention in patients with age-related macular degeneration: a randomized controlled trial.
Guo W, Wan J, Zhang F, Wu X, Hong Y, Wang Z, Bian W. · Front Public Health · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Association between diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysis.
Ghasemi M, Ghasemi A, Behjati J, Nikkhah H. · Graefes Arch Clin Exp Ophthalmol · 2026 · cited 1 timesmeta-analysis, systematic review
- Associations of dose adjustment with efficacy and safety of faricimab for age-related macular degeneration disorders: A systematic review and meta-analysis.
Benedictus B, Alaydrus ST, Ronik HK, Dwinastiti YA, Priscilla B, Nova E. · Arch Soc Esp Oftalmol (Engl Ed) · 2026 · cited 0 timesmeta-analysis, systematic review
- Age-related macular degeneration associated with glucagon-like peptide-1 receptor agonist use: a systematic review.
Al-Burak SA, Suleiman A, Voznyy V, Elganga M, Zajner C, Juncal V, Sheidow TG, Malvankar-Mehta MS. · Can J Ophthalmol · 2026 · cited 0 timessystematic review
- Different aflibercept regimens for wet age-related macular degeneration: A systematic review and network meta-analysis.
Chen YS, Chang HC, Chi SC, Tanaka K, Chen SJ, Lin TC. · J Chin Med Assoc · 2026 · cited 0 timesOpen accesssystematic review, network meta-analysis
- Community Optometrist-Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE Randomized Clinical Trial.
Sharma A, Jaber A, Pal B, Lawrenson JG, Harper RA, Tufail A, Learoyd AE, Robinson E, Douiri A, Burman R, Kernohan A, Vougioukalou S, Read S, Csontos J, Jones A, Mahmood S, McKibbin M, Peacock JL, Gale R, Patel PJ, Keane PA, Hamilton R, Vale L, Bunce C, Balaskas K. · JAMA Netw Open · 2026 · cited 0 timesOpen accessequivalence trial, research support, non-u.s. gov't
- Obstructive sleep apnea and risk of age-related macular degeneration: A systematic review and meta-analysis.
Yaldo L, Ngo A, Yaldo M, Abdelaal A, Ong J, Kiryakoza L, Sengillo J. · Am J Ophthalmol · 2026 · cited 0 timesmeta-analysis, systematic review
- Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial.
Watane A, Witkin A, Heier J, Shah C. · Am J Ophthalmol · 2026 · cited 1 timesmulticenter study, randomized controlled trial
- The potential of DNA methylation as a biomarker for age-related macular degeneration: A systematic review.
Ghannai S, Ribeiro E, Pereira B, Brito M, Camacho P. · Arch Soc Esp Oftalmol (Engl Ed) · 2026 · cited 0 timessystematic review, review
- Physical activity and the risk of cataract and age-related macular degeneration: a systematic review and meta-analysis of cohort studies.
Aune D, Jayedi A, Kazemi A, Soltani S, Rezaei F, Leitzmann MF. · BMC Ophthalmol · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.
Pitcher JD, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R. · JAMA Ophthalmol · 2026 · cited 1 timesOpen accessbrief-report, equivalence trial
- EQ-5D vision bolt-on in macular degeneration: associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy.
Zhu X, Wordsworth S, Lee CN, Wafa HA, Wang Y, Desai R, Ramazzotto L, Reeves BC, Jackson TL, Dakin H, STAR Study Group. · Health Qual Life Outcomes · 2026 · cited 1 timesOpen accessrandomized controlled trial
- Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic review.
Spooner KL, Fraser-Bell S, Fu DJ, Faes L, Romano F, Cozzi M, Chang AA, Sivaprasad S. · Front Ophthalmol (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.